Could the PD-1 Pathway Be a Potential Target for Treating Small Intestinal Adenocarcinoma?

Conclusions: PD-1 and PD-L1 are highly expressed by most small intestinal adenocarcinomas. Blockage of the PD-1 pathway should be evaluated in the treatment of small intestinal adenocarcinomas. PMID: 28821192 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/28821192?dopt=Abstract

Source: American Journal of Clinical Pathology - August 20, 2017 Category: Pathology Authors: Thota R, Gonzalez RS, Berlin J, Cardin DB, Shi C Tags: Am J Clin Pathol Source Type: research